Table: Daito - 6-MTH group results

Daito Pharmaceutical

14/01/2021 06:00

Jan 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2020        Nov 30, 2019     May 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               26.04               23.25            47.50    
                   (+12.0 pct)         (+15.4 pct)      (+5.6 pct)  
  Operating            3.51                2.83             4.95    
                   (+24.1 pct)         (+21.6 pct)      (-7.6 pct)  
  Recurring            3.56                2.88             5.00    
                   (+23.6 pct)         (+21.4 pct)      (-8.5 pct)  
  Net                  2.42                2.00             3.40    
                   (+21.0 pct)         (+19.7 pct)      (-13.8 pct) 
  EPS              178.30 yen          159.48 yen       252.96 yen  
  EPS Diluted                          158.58 yen                   
  Ann Div                               46.00 yen        46.00 yen  
  -Q2 div           23.00 yen           20.00 yen                   
  -Q4 div                               26.00 yen        23.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T